Tirzepatide warnings and precautions According to the FDA, there were some serious health issues that occurred in clinical trials of people taking tirzepatide, including: Pancreatitis Hypoglycemia Hypersensitivity reactions Acute kidney injury Severe gastrointestinal disease Diabetic retinopathy complications Acute gallbladder disease These are listed as precautionary because they were reported in a clinical trial, but there is not yet evidence that use of tirzepatide caused these issues
There is little research on the weight loss effect of EX on simple obesity patients, and more clinical trials are conducted on patients with T2DM
It can also be used to help manage type 2 diabetes, as well as improve overall health and wellbeing
Use of GLP-1 receptor agonists was associated with a lower rate of hyperkalemia than DPP-4 inhibitors (0.79, 0.77 to 0.82)
Piquereau J, Caffin F, Novotova M, Prola A, Garnier A, Mateo P, et al